These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15229275)

  • 41. Can [symbol: see text] verteporfin help in macular degeneration?
    Drug Ther Bull; 2001 Apr; 39(4):30-2. PubMed ID: 11329798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ophthalmology update for the primary practitioner. Part II. Therapeutic management of age-related macular degeneration.
    Sarrafizadeh R; Trese MT
    Dis Mon; 2000 Aug; 46(8):533-43. PubMed ID: 10969716
    [No Abstract]   [Full Text] [Related]  

  • 43. Systemic and ocular risks associated with therapies for macular degeneration: clarification vs confusion.
    Friberg TR; Shah V; Bilonick RA
    Arch Ophthalmol; 2012 Jun; 130(6):806-7; author reply 807. PubMed ID: 22801854
    [No Abstract]   [Full Text] [Related]  

  • 44. Age related macular degeneration.
    Arnold J; Sarks S
    Clin Evid; 2003 Dec; (10):727-43. PubMed ID: 15555119
    [No Abstract]   [Full Text] [Related]  

  • 45. Age related macular degeneration.
    Arnold J
    Clin Evid; 2005 Jun; (13):762-75. PubMed ID: 16135278
    [No Abstract]   [Full Text] [Related]  

  • 46. Age related macular degeneration.
    Arnold J; Sarks S
    Clin Evid; 2004 Jun; (11):819-34. PubMed ID: 15652038
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of retrobulbar blood flow by color doppler ultrasonography after intravitreal ranibizumab injection in patients with neovascular age-related macular degeneration.
    Sakalar YB; Senturk S; Yildirim M; Keklikci U; Alakus MF; Unlu K
    J Clin Ultrasound; 2013 Jan; 41(1):32-7. PubMed ID: 23055187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Contemporary approaches to the treatment of age-related macular degeneration in elderly patients.].
    Puzin SN; Nazarian MG; Vertash OY
    Adv Gerontol; 2019; 32(4):599-601. PubMed ID: 31800189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the ERG in the diagnosis and treatment of Age-Related Macular Degeneration.
    Gerth C
    Doc Ophthalmol; 2009 Feb; 118(1):63-8. PubMed ID: 18536949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
    Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
    Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the potential impact of using intravitreal angiostatic agents for wet macular degeneration on service capacity in a large retinal referral centre.
    Cheung CM; Peh KK; Yang Y
    Eye (Lond); 2007 Aug; 21(8):1121-2. PubMed ID: 17525768
    [No Abstract]   [Full Text] [Related]  

  • 52. [The place of photodynamic therapy in the treatment of age-related macular degeneration].
    Munteanu G
    Oftalmologia; 2004; 48(4):5-12. PubMed ID: 15782756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An update on photodynamic therapy in age-related macular degeneration.
    Rechtman E; Ciulla TA; Criswell MH; Pollack A; Harris A
    Expert Opin Pharmacother; 2002 Jul; 3(7):931-8. PubMed ID: 12083992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
    Bressler NM
    Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
    [No Abstract]   [Full Text] [Related]  

  • 55. [Photodynamic therapy carefully destroys neovascularization of the retina].
    Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
    [No Abstract]   [Full Text] [Related]  

  • 56. New perspectives on the treatment of age-related macular degeneration.
    Mones J
    Drugs Today (Barc); 2005 Nov; 41(11):701. PubMed ID: 16395410
    [No Abstract]   [Full Text] [Related]  

  • 57. Pegaptanib for neovascular age-related macular degeneration.
    Gragoudas ES; Adamis AP; Cunningham ET; Feinsod M; Guyer DR;
    N Engl J Med; 2004 Dec; 351(27):2805-16. PubMed ID: 15625332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
    Bressler NM; Bressler SB; Haynes LA; Hao Y; Kaiser PK; Miller JW; Naor J; Potter MJ; Pournaras CJ; Reaves A; Rosenfeld PJ; Schmidt-Erfurth U; Slakter JS; Strong A; Vannier S
    Arch Ophthalmol; 2005 Sep; 123(9):1283-5. PubMed ID: 16157822
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration.
    Larsson J; Gillies MC
    Clin Exp Ophthalmol; 2005 Oct; 33(5):544-5. PubMed ID: 16181292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Managing neovascular age-related macular degeneration: a step into the light.
    Guymer RH
    Med J Aust; 2007 Mar; 186(6):276-7. PubMed ID: 17371204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.